Next report date
Report period
Q1 2024
EPS estimate
−0.50NOK
Revenue estimate
64.37 MNOK
−371.59 MNOK
136.38 MNOK
154.63 M
Om NYKODE THERAPEUTICS ASA
Sektor
Bransch
VD
Michael Thyrring Engsig
Webbplats
Huvudkvarter
Oslo
Employees (FY)
167
Grundat
2006
ISIN
NO0010714785
FIGI
BBG00RKBJ0J2
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
